Free Republic

This is a very unique and extreme combination of exceptions that the US government made for Pfizer, that they didn’t make for Moderna or any other COVID-19 ‘vaccine’ manufacturer or subcontractor ... The NIH and Moderna own dozens of COVID-19 mRNA nanotechnology patents and were expecting BIG payouts from global COVID-19 ‘vaccine’ sales, especially from Pfizer. Per Pfizer’s December 12, 2022, mRNA Portfolio presentation by Navin Katyal, Pfizer has captured 63% of the global mRNA vaccine market. ... If one company received the royalty payouts on the global sales of Pfizer’s COVID-19 mRNA ‘vaccine’ alone, that company would likely be...

From: Recombinomics Commentary 16:53 March 24, 2009 Excerpt: "Reports from Taiwan also indicated that vaccines failed in 70% of the H1N1 cases and Tamiflu resistant H1N1 dominated in collections after December, 2008.Read more at Greg's BlogArticle continues: "Deb Brandt, a physician assistant at Rapid City Medical Center's Urgent Care, said that on Wednesday, the clinic checked in 106 people in 11 hours. There were cases of strep, mono and plenty of influenza. Three other Rapid City clinics report a similarly busy schedule. "Brandt said about half of her patients who tested positive for influenza had their shots, but "most of...